Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Current issue
Displaying 1-28 of 28 articles from this issue
Focus on issue: Arrhythmia / Electrophysiology
Original Articles
Catheter Ablation
  • Zhe Wang, Jiaju Li, Jiawei Chen, Hehe Guo, Haoming He, Siqi Jiao, Ying ...
    Article type: ORIGINAL ARTICLE
    Subject area: Catheter Ablation
    2024 Volume 88 Issue 7 Pages 1047-1054
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: November 01, 2023
    JOURNAL OPEN ACCESS FULL-TEXT HTML
    Supplementary material

    Background: Epicardial adipose tissue (EAT) is recognized as a clinical diagnostic marker for cardiometabolic disease. Thicker EAT may be associated with recurrence of ventricular tachycardia after ablation. The association between EAT volume and recurrence of premature ventricular complexes (PVC) following ablation has not been clarified. We investigated the association between EAT volume and PVC recurrence following radiofrequency catheter ablation.

    Methods and Results: This retrospective study included 401 patients with PVC undergoing catheter ablation with preprocedural non-contrast computed tomography between 2017 and 2022. The impact of EAT volume in predicting PVC recurrence after ablation was analyzed. The mean (±SD) age of patients was 50.2±13.3 years. Multivariable Cox analysis revealed that a large EAT volume was an independent predictor of PVC recurrence after ablation during a median follow-up of 16.3 months. Kaplan-Meier analysis showed a difference in postablation PVC recurrence between the 2 groups dichotomized around the EAT volume cut-off. The risk of recurrence increased with increasing EAT volume according to restricted cubic spline regression. Furthermore, PVC originating from epicardial locations had larger EAT volumes than those originating from the right ventricular outflow tract.

    Conclusions: A large EAT volume was independently associated with PVC recurrence following ablation. Patients with PVC originating from epicardial sites had large EAT volumes. EAT volume may help stratify patients according to their risk of PVC recurrence after ablation.

  • Ichitaro Abe, Naohiko Takahashi
    Article type: EDITORIAL
    2024 Volume 88 Issue 7 Pages 1055-1056
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: December 13, 2023
    JOURNAL OPEN ACCESS FULL-TEXT HTML
  • Naoaki Onishi, Kazuaki Kaitani, Yoshihisa Nakagawa, Atsushi Kobori, Ko ...
    Article type: ORIGINAL ARTICLE
    Subject area: Catheter Ablation
    2024 Volume 88 Issue 7 Pages 1057-1064
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: January 11, 2024
    JOURNAL OPEN ACCESS FULL-TEXT HTML
    Supplementary material

    Background: Catheter ablation (CA) for atrial fibrillation (AF) in patients on hemodialysis (HD) is reported to have a high risk of late recurrence (LR). However, the relationship between early recurrence (ER) within a 90-day blanking period after CA in AF patients and LR in HD patients remains unclear.

    Methods and Results: Of the 5,010 patients in the Kansai Plus Atrial Fibrillation Registry, 5,009 were included in the present study. Of these patients, 4,942 were not on HD (non-HD group) and 67 were on HD (HD group). HD was an independent risk factor for LR after the initial CA (adjusted hazard ratio 1.6; 95% confidence interval 1.1–2.2; P=0.01). In patients with ER, the rate of sinus rhythm maintenance at 3 years after the initial CA was significantly lower in the HD than non-HD group (11.4% vs. 35.4%, respectively; log-rank P=0.004). However, in patients without ER, there was no significant difference in the rate of sinus rhythm maintenance at 3 years between the HD and non-HD groups (67.7% vs. 74.5%, respectively; log-rank P=0.62).

    Conclusions: ER in HD patients was a strong risk factor for LR. However, even HD patients could expect a good outcome without ER after the initial CA.

  • Masaomi Kimura
    Article type: EDITORIAL
    2024 Volume 88 Issue 7 Pages 1065-1067
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: February 16, 2024
    JOURNAL OPEN ACCESS FULL-TEXT HTML
  • Yasuharu Matsunaga-Lee, Koichi Inoue, Nobuaki Tanaka, Masaharu Masuda, ...
    Article type: ORIGINAL ARTICLE
    Subject area: Catheter Ablation
    2024 Volume 88 Issue 7 Pages 1068-1077
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: May 30, 2024
    JOURNAL OPEN ACCESS FULL-TEXT HTML
    Supplementary material

    Background: It has not been fully elucidated which patients with persistent atrial fibrillation (PerAF) should undergo substrate ablation plus pulmonary vein isolation (PVI). This study aimed to identify PerAF patients who required substrate ablation using intraprocedural assessment of the baseline rhythm and the origin of atrial fibrillation (AF) triggers.

    Methods and Results: This was a post hoc subanalysis using extended data of the EARNEST-PVI trial, a prospective multicenter randomized trial comparing PVI-alone and PVI-plus (i.e., PVI with added catheter ablation) arms. We divided 492 patients into 4 groups according to baseline rhythm and the location of AF triggers before PVI: Group A (n=22), sinus rhythm with pulmonary vein (PV)-specific AF triggers (defined as reproducible AF initiation from PVs only); Group B (n=211), AF with PV-specific AF triggers; Group C (n=94), sinus rhythm with no PV-specific AF trigger; Group D (n=165), AF with no PV-specific AF trigger. Among the 4 groups, only in Group D (AF at baseline and no PV-specific AF triggers) was arrhythmia-free survival significantly lower in the PVI-alone than PVI-plus arm (P=0.032; hazard ratio 1.68; 95% confidence interval 1.04–2.70).

    Conclusions: Patients with sinus rhythm or PV-specific AF triggers did not receive any benefit from substrate ablation, whereas patients with AF and no PV-specific AF trigger benefited from substrate ablation.

  • Shinsuke Miyazaki
    Article type: EDITORIAL
    2024 Volume 88 Issue 7 Pages 1078-1080
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: June 04, 2024
    JOURNAL OPEN ACCESS FULL-TEXT HTML
  • Hibiki Iwakoshi, Yusuke C Asada, Mitsuko Nakata, Masahiro Makino, Jun ...
    Article type: ORIGINAL ARTICLE
    Subject area: Catheter Ablation
    2024 Volume 88 Issue 7 Pages 1081-1088
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: January 27, 2024
    JOURNAL OPEN ACCESS FULL-TEXT HTML
    Supplementary material

    Background: The impact of sleep apnea (SA) on heart rate variability (HRV) in atrial fibrillation (AF) patients has not been investigated.

    Methods and Results: Of 94 patients who underwent AF ablation between January 2021 and September 2022, 76 patients who had a nocturnal Holter electrocardiography and polysomnography conducted simultaneously were included in the analysis. A 15-min duration of HRV, as determined by an electrocardiogram during apnea and non-apnea time, were compared between patients with and without AF recurrence at 12 months’ postoperatively. Patients had a mean age of 63.4±11.6 years, 14 were female, and 20 had AF recurrence at 12 months’ follow-up. The root mean square of the difference between consecutive normal-to-normal intervals (RMSSD, ms) an indicator of a parasympathetic nervous system, was more highly increased in patients with AF recurrence than those without, during both apnea and non-apnea time (apnea time: 16.7±4.5 vs. 13.5±3.3, P=0.03; non-apnea time: 20.9±9.5 vs. 15.5±5.9, P<0.01). However, RMSSD during an apneic state was decreased more than that in a non-apneic state in both groups of patients with and without AF recurrence (AF recurrence group: 16.7±4.5 vs. 20.9±9.5, P<0.01; non-AF recurrence group; 13.5±3.3 vs. 15.5±5.9, P=0.03). Consequently, the effect of AF recurrence on parasympathetic activity was offset by SA. Similar trends were observed for other parasympathetic activity indices; high frequency (HF), logarithm of HF (lnHF) and the percentage of normal-to-normal intervals >50 ms (pNN50).

    Conclusions: Without considering the influence of SA, the results of nocturnal HRV analysis might be misinterpreted. Caution should be taken when using nocturnal HRV as a predictor of AF recurrence.

  • Ling Kuo, Guan-Jie Wang, Shih-Ling Chang, Yenn-Jiang Lin, Fa-Po Chung, ...
    Article type: ORIGINAL ARTICLE
    Subject area: Catheter Ablation
    2024 Volume 88 Issue 7 Pages 1089-1098
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: February 14, 2024
    JOURNAL OPEN ACCESS FULL-TEXT HTML
    Supplementary material

    Background: The aim of this study was to build an auto-segmented artificial intelligence model of the atria and epicardial adipose tissue (EAT) on computed tomography (CT) images, and examine the prognostic significance of auto-quantified left atrium (LA) and EAT volumes for AF.

    Methods and Results: This retrospective study included 334 patients with AF who were referred for catheter ablation (CA) between 2015 and 2017. Atria and EAT volumes were auto-quantified using a pre-trained 3-dimensional (3D) U-Net model from pre-ablation CT images. After adjusting for factors associated with AF, Cox regression analysis was used to examine predictors of AF recurrence. The mean (±SD) age of patients was 56±11 years; 251 (75%) were men, and 79 (24%) had non-paroxysmal AF. Over 2 years of follow-up, 139 (42%) patients experienced recurrence. Diabetes, non-paroxysmal AF, non-pulmonary vein triggers, mitral line ablation, and larger LA, right atrium, and EAT volume indices were linked to increased hazards of AF recurrence. After multivariate adjustment, non-paroxysmal AF (hazard ratio [HR] 0.6; 95% confidence interval [CI] 0.4–0.8; P=0.003) and larger LA-EAT volume index (HR 1.1; 95% CI 1.0–1.2; P=0.009) remained independent predictors of AF recurrence.

    Conclusions: LA-EAT volume measured using the auto-quantified 3D U-Net model is feasible for predicting AF recurrence after CA, regardless of AF type.

  • Kensuke Yokoi, Tomonori Katsuki, Takanori Yamaguchi, Toyokazu Otsubo, ...
    Article type: ORIGINAL ARTICLE
    Subject area: Catheter Ablation
    2024 Volume 88 Issue 7 Pages 1099-1106
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: March 16, 2024
    JOURNAL OPEN ACCESS FULL-TEXT HTML
    Supplementary material

    Background: Pulmonary vein (PV) stenosis (PVS) is a serious complication of atrial fibrillation (AF) ablation. The objective of this study was to describe interventional treatments for PVS after AF ablation and long-term outcomes in Japanese patients.

    Methods and Results: This multicenter retrospective observational study enrolled 30 patients (26 [87%] male; median age 55 years) with 56 severe PVS lesions from 43 PV interventional procedures. Twenty-seven (90%) patients had symptomatic PVS and 19 (63%) had a history of a single AF ablation. Of the 56 lesions, 41 (73%) were de novo lesions and 15 (27%) were retreated. Thirty-three (59%) lesions were treated with bare metal stents, 14 (25%) were treated with plain balloons, and 9 (16%) were treated with drug-coated balloons. All lesions were successfully treated without any systemic embolic event. Over a median follow-up of 584 days (interquartile range 265–1,165 days), restenosis rates at 1 and 2 years were 35% and 47%, respectively. Multivariate Cox regression analysis revealed devices <7 mm in diameter (hazard ratio [HR] 2.52; 95% confidence interval [CI] 1.04–6.0; P=0.040) and totally occluded lesions (HR 3.33; 95% CI 1.21–9.15; P=0.020) were independent risk factors for restenosis.

    Conclusions: All PVS lesions were successfully enlarged by the PV intervention; however, restenosis developed in approximately half the lesions within 2 years.

Devices
  • Yusuke Kondo, Takashi Noda, Yukiko Takanashi, Shingo Sasaki, Yasunori ...
    Article type: ORIGINAL ARTICLE
    Subject area: Devices
    2024 Volume 88 Issue 7 Pages 1107-1114
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: December 07, 2023
    JOURNAL OPEN ACCESS FULL-TEXT HTML

    Background: In 2016, the DANISH study reported negative results regarding the efficacy of implantable cardioverter-defibrillators (ICDs) in patients with non-ischemic cardiomyopathy (NICM) and reduced left ventricular ejection fraction (LVEF). In this study we determined the efficacy of using ICDs for primary prophylaxis in patients with NICM.

    Methods and Results: We selected 1,274 patients with underlying cardiac disease who were enrolled in the Nippon Storm Study. We analyzed the data of 451 patients with LVEF ≤35% due to NICM or ischemic cardiomyopathy (ICM) who underwent ICD implantation for primary prophylaxis (men, 78%; age, 65±12 years; LVEF, 25±6.4%; cardiac resynchronization therapy, 73%; ICM, 33%). After propensity score matching, we compared the baseline covariates between groups: NICM (132 patients) and ICM (132 patients). The 2-year appropriate ICD therapy risks were 27.7% and 12.2% in the NICM and ICM groups, respectively (hazard ratio, 0.390 [95% confidence interval, 0.218–0.701]; P=0.002).

    Conclusions: This subanalysis of propensity score-matched patients from the Nippon Storm Study revealed that the risk of appropriate ICD therapy was significantly higher in patients with NICM than in those with ICM.

  • Toshiko Nakai
    Article type: EDITORIAL
    2024 Volume 88 Issue 7 Pages 1115-1117
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: December 07, 2023
    JOURNAL OPEN ACCESS FULL-TEXT HTML
  • Yoshinari Enomoto, Takanori Ikeda, Keijiro Nakamura, Mahito Noro, Kaor ...
    Article type: ORIGINAL ARTICLE
    Subject area: Devices
    2024 Volume 88 Issue 7 Pages 1118-1124
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: April 12, 2024
    JOURNAL OPEN ACCESS FULL-TEXT HTML

    Background: Despite an increased incidence of chronic heart failure (HF) and sudden cardiac death (SCD), the use of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) is much lower in Japan than in Western countries. The HF Indication and SCD Prevention Trial Japan (HINODE) prospectively assessed the mortality rate, appropriately treated ventricular arrhythmias (VA), and HF in Japanese patients with a higher risk of HF.

    Methods and Results: HINODE consisted of ICD, CRT-defibrillator (CRT-D), pacing, and non-device treatment cohorts. This subanalysis evaluated the impact of the implantation of high-voltage devices (HVD; ICD and CRT-D) in 171 Japanese patients. We compared all-cause mortality, VA, and HF events between elderly (age >70 years at study enrollment) and non-elderly HVD recipients. The estimated survival rate through 24 months in the HVD cohort was 85.8% (97.5% lower control limit 77.6%). The risk of all-cause mortality was increased for the elderly vs. non-elderly (hazard ratio [HR] 2.82; 95% confidence interval [CI] 1.01–7.91; P=0.039), but did not differ after excluding ICD patients with CRT-D indication (HR 2.32; 95% CI 0.79–6.78; P=0.11). There were no differences in VA and HF event-free rates between elderly and non-elderly HVD recipients (P=0.73 and P=0.55, respectively).

    Conclusions: Although elderly patients may have a higher risk of mortality in general, the benefit of HVD therapy in this group is comparable to that in non-elderly patients.

  • Ritsuko Kohno, Katsuhide Hayashi, Yasushi Oginosawa, Haruhiko Abe
    Article type: EDITORIAL
    2024 Volume 88 Issue 7 Pages 1125-1126
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: May 17, 2024
    JOURNAL OPEN ACCESS FULL-TEXT HTML
  • Kyoko Soejima, Kathryn Hilpisch, Megan L. Samec, Rebecca L. Temple, Ma ...
    Article type: ORIGINAL ARTICLE
    Subject area: Devices
    2024 Volume 88 Issue 7 Pages 1127-1134
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: April 24, 2024
    JOURNAL OPEN ACCESS FULL-TEXT HTML

    Background: The Micra leadless pacemaker was developed to fit inside the right ventricle, thereby reducing overall complications by 48% compared with a historical control group. The current labeling restricts implants to the femoral approach. In this article we used 3-dimensional computer models of human hearts to demonstrate why implants can be difficult in small patients and how using the jugular approach reduces these difficulties.

    Methods and Results: Cardiac computed tomography scans were made of 45 pacemaker patients, 26 in the US and 19 from a single center in Japan. Dimensional measurements were taken in all 45 hearts, and these dimensions were compared between patient cohorts and between the Micra delivery tool dimension and patient heart dimensions. Hearts were smaller among patients in the Japanese than US cohort. In addition, the tool dimension exceeded heart dimensions in a larger percentage of hearts from Japanese patients. Three dimensions were identified that most likely limit navigating across the tricuspid valve to the right ventricle in smaller hearts and for which the jugular approach improved navigation.

    Conclusions: Although the femoral procedure today maintains an excellent safety profile and procedure experience for most global implants, this study provides the rationale as to why the jugular approach may improve the ease of the Micra implant in small hearts, namely by reducing the tortuosity of the navigation across the tricuspid valve.

  • Kohei Ishibashi, Kengo Kusano
    Article type: EDITORIAL
    2024 Volume 88 Issue 7 Pages 1135-1137
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: June 04, 2024
    JOURNAL OPEN ACCESS FULL-TEXT HTML
  • Nobuhiko Ueda, Takashi Noda, Koshiro Kanaoka, Yuichiro Miyazaki, Akino ...
    Article type: ORIGINAL ARTICLE
    Subject area: Devices
    2024 Volume 88 Issue 7 Pages 1138-1146
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: December 05, 2023
    JOURNAL OPEN ACCESS FULL-TEXT HTML
    Supplementary material

    Background: Atrial tachyarrhythmias (ATAs) are reportedly associated with ventricular arrhythmias (VAs). However, little is known about the association between ATA duration and the risk of VA. We investigated the relationship between ATA duration and subsequent VA in patients with a cardiac resynchronization therapy defibrillator (CRT-D).

    Methods and Results: We investigated associations between the longest ATA duration during the first year after cardiac resynchronization therapy (CRT) implantation and VA and VA relevant to ATA (VAATA) in 160 CRT-D patients. ATAs occurred in 63 patients in the first year. During a median follow-up of 925 days from 1 year after CRT implantation, 40 patients experienced 483 VAs. Kaplan-Meier analysis showed a significantly higher risk of VA in patients with than without ATA in the first year (log rank P=0.0057). Hazard ratios (HR) of VA (HR 2.36, 2.10, and 3.04 for ATA >30s, >6 min and >24 h, respectively) and only VAATA (HR 4.50, 5.59, and 11.79 for ATA >30s, >6 min and >24 h, respectively) increased according to the duration of ATA. In multivariate analysis, ATA >24 h was an independent predictor of subsequent VA (HR 2.42; P=0.02).

    Conclusions: Patients with ATA >24 h in the first year after CRT had a higher risk of subsequent VA and VAATA. The risk of VA, including VAATA, increased with the longest ATA duration.

  • Akira Kasagawa, Ikutaro Nakajima, Yui Nakayama, Daisuke Togashi, Kenic ...
    Article type: ORIGINAL ARTICLE
    Subject area: Devices
    2024 Volume 88 Issue 7 Pages 1147-1154
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: February 02, 2024
    JOURNAL OPEN ACCESS FULL-TEXT HTML
    Supplementary material

    Background: High shock impedance is associated with conversion failure among patients with subcutaneous implantable cardioverter defibrillators (S-ICD). Currently, there is no preoperative assessment method for predicting high shock impedance. This study examined the efficacy of chest computed tomography (CT) as a preoperative evaluation tool to assess the shock impedance of S-ICDs.

    Methods and Results: The amount of adipose tissue adjacent to the device and anteroposterior diameter at the basal heart region were measured preoperatively using chest CT. We examined the correlation between these measurements and shock impedance at the conversion test. We enrolled 43 patients with S-ICDs (mean [±SD] age 54±15 years; body mass index 23±4 kg/m2; PRAETORIAN score 30–270 points; amount of adipose tissue 1,250±716 cm3), who underwent intraoperative conversion tests by inducing ventricular fibrillation, which was terminated with a 65-J shock. A sufficient concordance correlation coefficient was observed between the shock impedance and the amount of adipose tissue (r=0.616, P<0.01) and anteroposterior diameter (r=0.645, P<0.01). In multiple regression analysis, the amount of adipose tissue (β=0.439, P=0.009) and anteroposterior diameter (β=0.344, P=0.038) were identified as independent predictive factors of shock impedance.

    Conclusions: The preoperative CT-measured amount of adipose tissue and basal heart anteroposterior diameter are independent predictors of shock impedance. These parameters may be more accurate in identifying higher shock impedance in patients with S-ICDs.

Atrial Fibrillation
  • Ken-ichi Hiasa, Hidetaka Kaku, Hiroshi Inoue, Takeshi Yamashita, Masah ...
    Article type: ORIGINAL ARTICLE
    Subject area: Atrial Fibrillation
    2024 Volume 88 Issue 7 Pages 1155-1164
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: October 28, 2023
    JOURNAL OPEN ACCESS FULL-TEXT HTML
    Supplementary material

    Background: This prospective ANAFIE Registry substudy investigated the relationship between the echocardiographic parameters of left atrial (LA) structure and function and clinical outcomes at 2 years among atrial fibrillation (AF) patients aged ≥75 years.

    Methods and Results: Outcomes of 1,474 elderly non-valvular AF (NVAF) patients who underwent transthoracic echocardiography at baseline were analyzed by categories of maximum LA volume index (max. LAVi) and LA emptying fraction (LAEF) total. Baseline mean±standard deviation LAEF total and max. LAVi were 28.2±14.9% and 54.2±25.9 mL/m2, respectively. Proportions of oral anticoagulant (OAC), direct OAC, and warfarin use were 92.7%, 68.7%, and 24.0%, respectively. Patients with LAEF total ≤45.0% (n=1,213) vs. >45.0% (n=224) were at higher risk of cardiovascular events (hazard ratio [HR]: 2.19, P=0.021) and heart failure (HF) hospitalization (HR: 2.25, P=0.045). Risk of all-cause death was higher with max. LAVi >48.0 mL/m2(n=656) vs. ≤48.0 mL/m2(n=621) (HR: 1.69, P=0.048). Subgroups with abnormal LA function and structure had increased incidence of cardiac/cardiovascular events and HF hospitalization. No significant interaction was observed between echocardiographic parameters and OAC type.

    Conclusions: Elderly Japanese patients with NVAF and LAEF total ≤45.0% were at higher risk of cardiovascular events and HF hospitalization, and those with max. LAVi >48.0 mL/m2were at higher risk of all-cause death.

  • Katsuji Inoue
    Article type: EDITORIAL
    2024 Volume 88 Issue 7 Pages 1165-1166
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: December 09, 2023
    JOURNAL OPEN ACCESS FULL-TEXT HTML
  • Hirochika Yamasaki, Hidekazu Kondo, Tomoaki Shiroo, Naohiro Iwata, Ter ...
    Article type: ORIGINAL ARTICLE
    Subject area: Atrial Fibrillation
    2024 Volume 88 Issue 7 Pages 1167-1175
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: March 22, 2024
    JOURNAL OPEN ACCESS FULL-TEXT HTML

    Background: The prevalence of transthyretin amyloid cardiomyopathy (ATTR-CM) in atrial fibrillation (AF) patients remains unclear. We explored the efficacy of computed tomography-based myocardial extracellular volume (CT-ECV) combined with red flags for the early screening of concealed ATTR-CM in AF patients undergoing catheter ablation.

    Methods and Results: Patients referred for AF ablation at Oita University Hospital were prescreened using the red-flag signs defined by echocardiographic or electrocardiographic findings, medical history, symptoms, and blood biochemical findings. Myocardial CT-ECV was quantified in red flag-positive patients using routine pre-AF ablation planning cardiac CT with the addition of delayed-phase cardiac CT scans. Patients with high (>35%) ECV were evaluated using technetium pyrophosphate (99 mTc-PYP) scintigraphy. A cardiac biopsy was performed during the planned AF ablation procedure if 99 mTc-PYP scintigraphy was positive. Between June 2022 and June 2023, 342 patients were referred for AF ablation. Sixty-seven (19.6%) patients had at least one of the red-flag signs. Myocardial CT-ECV was evaluated in 57 patients because of contraindications to contrast media, revealing that 16 patients had high CT-ECV. Of these, 6 patients showed a positive 99 mTc-PYP study, and 6 patients were subsequently diagnosed with wild-type ATTR-CM via cardiac biopsy and genetic testing.

    Conclusions: CT-ECV combined with red flags could contribute to the systematic early screening of concealed ATTR-CM in AF patients undergoing catheter ablation.

Others
  • Masao Yoshinaga, Yumiko Ninomiya, Yuji Tanaka, Megumi Fukuyama, Koichi ...
    Article type: ORIGINAL ARTICLE
    2024 Volume 88 Issue 7 Pages 1176-1184
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: December 01, 2023
    JOURNAL OPEN ACCESS FULL-TEXT HTML
    Supplementary material

    Background: This study was performed to clarify the clinical findings of pediatric patients diagnosed with long QT syndrome (LQTS) through electrocardiographic screening programs and to predict their outcome using Holter electrocardiographic approaches.

    Methods and Results: This retrospective study included pediatric patients with a Schwartz score of ≥3.5 who visited the National Hospital Organization Kagoshima Medical Center between April 2005 and March 2019. Resting 12-lead and Holter electrocardiograms were recorded at every visit. The maximum resting QTc and maximum Holter QTc values among all recordings were used for statistical analyses. To test the prognostic value of QTc for the appearance of cardiac events after the first hospital visit, receiver operating characteristic curves were used to calculate the area under the curve (AUC). Among 207 patients, 181 (87%) were diagnosed through screening programs. The prevalence of cardiac events after the first hospital visit was 4% (8/207). Among QTc at diagnosis, maximum resting QTc, and maximum Holter QTc, only maximum Holter QTc value was a predictor (P=0.02) of cardiac events after the hospital visit in multivariate regression analysis. The AUC of the maximum Holter QTc was significantly superior to that of maximum resting QTc.

    Conclusions: The maximum Holter QTc value can be used to predict the appearance of symptoms in pediatric patients with LQTS.

  • Keiko Shimamoto, Takeshi Aiba
    Article type: EDITORIAL
    2024 Volume 88 Issue 7 Pages 1185-1186
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: December 29, 2023
    JOURNAL OPEN ACCESS FULL-TEXT HTML
Late Breaking Cohort Studies (JCS 2024)
  • Masaki Nakashima, Masanori Yamamoto, Mitsuru Sago, Shuhei Tanaka, Ryuk ...
    Article type: LATE BREAKING COHORT STUDY (JCS 2024)
    2024 Volume 88 Issue 7 Pages 1187-1197
    Published: June 25, 2024
    Released on J-STAGE: June 25, 2024
    Advance online publication: May 17, 2024
    JOURNAL OPEN ACCESS FULL-TEXT HTML
    Supplementary material

    Background: Limited data are available regarding clinical outcomes after percutaneous left atrial appendage closure using WATCHMAN FLX (WM-FLX) and WATCHMAN-2.5 (WM2.5) devices in Asian patients.

    Methods and Results: Data of 1,464 consecutive patients (WM-FLX, n=909; WM2.5, n=555) were extracted from a Japanese multicenter registry, and clinical data were compared between the 2 groups. No in-hospital deaths, periprocedural stroke, or device embolization occurred. Procedural success was significantly higher in the WM-FLX than WM2.5 group (95.8% vs. 91.9%; P=0.002) owing to the lower incidence of periprocedural pericardial effusion (0.55% vs. 1.8%; P=0.021). No significant differences in all-cause death, postprocedural stroke, and device-related thrombus were observed between the 2 groups. However, the cumulative bleeding rate at 1 year was substantially lower in the WM-FLX group (7.8% vs. 16.4%; P<0.001). Landmark analysis of bleeding events highlighted lower bleeding rates in the WM-FLX than WM2.5 group within the first 6 months (6.4% vs. 14.8%; P<0.001), with comparable bleeding rates over the 6- to 12-month period (1.5% vs. 3.2%, respectively; P=0.065).

    Conclusions: This study demonstrated higher early safety and lower 1-year bleeding rates in the WM-FLX than WM2.5 group. The lower bleeding events with WM-FLX are likely due to multiple factors other than purely difference in devices, such as postprocedural drug regimen.

Images in Cardiovascular Medicine
feedback
Top